HFpEF in HCM predicts poor outcome
Heart failure with preserved ejection fraction (HFpEF) in hypertrophic cardiomyopathy (HCM) has been identified as a major independent predictor of adverse outcomes in a new large-scale machine learning-powered study, highlighting an under-recognized high-risk patient subgroup. HCM is a genetic heart disease characterized by abnormal thickening of the myocardium and has long been associated with a […]
Continue Reading